We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Says Cancer Drug Surrogate Endpoints Will Be Released for First Time
Gottlieb Says Cancer Drug Surrogate Endpoints Will Be Released for First Time
In the coming weeks, CDER will publish online a list of surrogate endpoints that led to the approval of oncology drugs and biologicals for the first time, FDA Commissioner Scott Gottlieb announced at the National Comprehensive Cancer Network Policy Summit in Washington, D.C.